December 17, 2020 06:27 AM ESTUpdated December 18, 12:21 PM
Financing
China

Ab­b­Vie's Covid-19 an­ti­body part­ner wraps $221M Hong Kong IPO

Amber Tong

Just a few days af­ter Ab­b­Vie went all in on a Covid-19 an­ti­body, its part­ner has of­fi­cial­ly wrapped its IPO.

List­ing on the Hong …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

Ex­clu­sive: Re­boot­ing dead hu­man brains, a biotech start­up seeks to rein­vent ear­ly drug test­ing work

FDA places hold on Gilead­'s stud­ies of HIV treat­ment pill com­bo

Ex­clu­sive: Scor­pi­on spin­out gets $177M for stealthy pipeline amid Chi­na com­pe­ti­tion

Post-Hoc Live: The fall­out from RFK Jr.’s fir­ing of ACIP, with ex-CDC Di­rec­tor Mandy Co­hen

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times